Mesa Biotech: Thermo Fisher to Acquire Mesa Biotech in Deal Worth up to $550M
Thermo Fisher Scientific Inc. (NYSE: TMO) will acquire San Diego diagnostic company, Mesa Biotech Inc. for around $450 million in cash, the firm announced on Jan. 19.
Read full article »
Mesa Biotech is a biotechnology company that designs, develops, manufactures and commercializes molecular diagnostic tests.
Read more